PureTech Health plc (NASDAQ:PRTC) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the PureTech Health 2024 Half Year Results Conference Call. At this time, all participants are in listen-only mode.
Puretech Health Plc (PRTC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 45,264 | $822,900 | 0% | |
| 2. | Pentwater Capital Management Matthew Halbower | 24,111 | $445,089 | -4% | 0% |
| 3. | ADAR1 Capital Management Daniel Schneeberger | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 302,000 | $567,727 | 0.02% | |
| 2. | 1,903 | $35,129 | 0% | |
| 3. | 100 | $1,846 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
PureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the PureTech Health 2023 Year End Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
10 Best Immunology Stocks to Invest In
Immunology is the study of the immune system of higher organisms in relation to disease.
Billionaire Hedge Funds
